← Back to Search

Cognitive Behavioral Therapy for Prodromal

N/A
Waitlist Available
Led By Yulia Landa, Psy.D., M.S.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline, post-cbt (month 5), and at follow-up assessments (months 9, 13, 17, 21, 25 and 29)
Awards & highlights
No Placebo-Only Group

Summary

The main objective of this study is to decrease the severity of symptoms and improve psycho-social functioning in youth at high risk of developing psychosis by providing a specialized Group-and-Family-based Cognitive Behavioral Therapy (GF-CBT).

Eligible Conditions
  • Prodromal
  • Amyotrophic lateral sclerosis
  • Antiphospholipid syndrome
  • Prodromal Symptoms

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline, post-cbt (month 5), and at follow-up assessments (months 9, 13, 17, 21, 25 and 29)
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at baseline, post-cbt (month 5), and at follow-up assessments (months 9, 13, 17, 21, 25 and 29) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in CAARMS from Baseline
Secondary study objectives
Change from Baseline in a Tendency to Jump to Conclusions
Change in Anxiety Symptoms from Baseline
Change in Cognitive Biases from Baseline
+7 more
Other study objectives
Change in Family Member's CBT Skills from Baseline
Group Cohesiveness Scale (GCS)
The Empathy Scale (ES)
+2 more

Side effects data

From 2021 Phase 4 trial • 12 Patients • NCT04135937
8%
irritability
100%
80%
60%
40%
20%
0%
Study treatment Arm
MESH

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Behavioral TherapyExperimental Treatment1 Intervention
Cognitive Behavioral Therapy group receives group, individual, and family Cognitive Behavioral Therapy in addition to standard care.
Group II: MonitoringActive Control1 Intervention
This group receives standard care only.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioral Therapy
2016
Completed Phase 4
~3120

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,084 Previous Clinical Trials
1,147,299 Total Patients Enrolled
Sidney R. Baer, Jr. FoundationOTHER
2 Previous Clinical Trials
46 Total Patients Enrolled
Yulia Landa, Psy.D., M.S.Principal InvestigatorIcahn School of Medicine at Mount Sinai
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top